Diabetes drug effective against heart failure in wide spectrum of patients
Monday, March 18, 2019 - 14:30
in Health & Medicine
The cardiovascular benefits of the diabetes drug dapagliflozin extend across a wide spectrum of patients and are especially pronounced in those with reduced ejection fraction, a measure of the heart's pumping ability indicative of poor heart functioning, according to new research.